← Evidence map

ArticleEndocrinology, diabetes & metabolism case reports2021

Cabergoline reduces 3-methoxytyramine in a SDHC patient with metastatic paraganglioma and prolactinoma.

Ziad Hussein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34110302